Literature DB >> 20869864

Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function.

Yan Xiao1, Bin Li, Zhaocai Zhou, Wayne W Hancock, Hongtao Zhang, Mark I Greene.   

Abstract

Regulatory T cells (Tregs) are required for the maintenance of immune homeostasis as first clearly described by Herman Waldmann's laboratory. Dysfunction of Treg cells also leads to fatal autoimmunity in humans and mice. Conversely, the activation of different classes of Tregs operative systemically and within the cancer microenvironment can suppress host anti-tumor immune responses and promote tumor progression. Therefore, the development of new therapeutic approaches to regulate the activity of Treg cells may have considerable clinical potential. FOXP3 is the key transcriptional regulator of Treg development and function. The activity of FOXP3 is regulated by acetylation, a process catalyzed by distinct types of histone/protein acetyltransferases (HATs) that regulate the functions of many transcription factors, independently of FOXP3, as well as non-histone proteins, in addition to their effects on chromatin accessibility. Interactions between FOXP3 and these enzymes determine the suppressive function of FOXP3. Clearly, small molecules targeting these enzymes are candidates for the regulation of Treg function in vaccines and tumor therapies. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869864      PMCID: PMC2967626          DOI: 10.1016/j.coi.2010.08.013

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  88 in total

1.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

Review 2.  Transcriptional regulation of the IL-2 gene.

Authors:  J Jain; C Loh; A Rao
Journal:  Curr Opin Immunol       Date:  1995-06       Impact factor: 7.486

3.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

4.  The CBP co-activator is a histone acetyltransferase.

Authors:  A J Bannister; T Kouzarides
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

5.  Nuclear protein CBP is a coactivator for the transcription factor CREB.

Authors:  R P Kwok; J R Lundblad; J C Chrivia; J P Richards; H P Bächinger; R G Brennan; S G Roberts; M R Green; R H Goodman
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

6.  E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators.

Authors:  Z Arany; W R Sellers; D M Livingston; R Eckner
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

Review 7.  Acetylation of general transcription factors by histone acetyltransferases.

Authors:  A Imhof; X J Yang; V V Ogryzko; Y Nakatani; A P Wolffe; H Ge
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

8.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.

Authors:  X J Yang; V V Ogryzko; J Nishikawa; B H Howard; Y Nakatani
Journal:  Nature       Date:  1996-07-25       Impact factor: 49.962

9.  Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator.

Authors:  J Kamine; B Elangovan; T Subramanian; D Coleman; G Chinnadurai
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

10.  Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation.

Authors:  J W Rooney; Y L Sun; L H Glimcher; T Hoey
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  47 in total

Review 1.  Histone/protein deacetylases and T-cell immune responses.

Authors:  Tatiana Akimova; Ulf H Beier; Yujie Liu; Liqing Wang; Wayne W Hancock
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

Review 2.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

3.  Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells.

Authors:  Hye-Sook Kwon; Hyung W Lim; Jessica Wu; Martina Schnölzer; Eric Verdin; Melanie Ott
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

4.  Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation.

Authors:  Guoping Deng; Yasuhiro Nagai; Yan Xiao; Zhiyuan Li; Shujia Dai; Takuya Ohtani; Alison Banham; Bin Li; Shiaw-Lin Wu; Wayne Hancock; Arabinda Samanta; Hongtao Zhang; Mark I Greene
Journal:  J Biol Chem       Date:  2015-05-18       Impact factor: 5.157

Review 5.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

6.  Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function.

Authors:  Xiaomin Song; Bin Li; Yan Xiao; Chunxia Chen; Qiang Wang; Yujie Liu; Alan Berezov; Chen Xu; Yayi Gao; Zhiyuan Li; Shiaw-Lin Wu; Zheng Cai; Hongtao Zhang; Barry L Karger; Wayne W Hancock; Andrew D Wells; Zhaocai Zhou; Mark I Greene
Journal:  Cell Rep       Date:  2012-06-15       Impact factor: 9.423

Review 7.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

8.  Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity.

Authors:  Kailin Yan; Qiang Cao; Christopher M Reilly; Nicolas L Young; Benjamin A Garcia; Nilamadhab Mishra
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

Review 9.  Modulation of antitumor immunity with histone deacetylase inhibitors.

Authors:  Tyler R McCaw; Troy D Randall; Andres Forero; Donald J Buchsbaum
Journal:  Immunotherapy       Date:  2017-12       Impact factor: 4.196

Review 10.  Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

Authors:  Guoping Deng; Yan Xiao; Zhaocai Zhou; Yasuhiro Nagai; Hongtao Zhang; Bin Li; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2012-10-02       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.